1-4 of 4
constraint-induced movement therapy
Close
Sort by
Journal Articles

Cpit (Check Point Inhibitor Trial) 002: Phase I Study of Single-Agent and Combined Checkpoint Inhibition (CI) after Allogenic Hematopoietic Stem Cell Transplantation (alloHCT) in Patients at High Risk for Post-Transplant Recurrence

Jamie Koprivnikar, MD, James K McCloskey, MD, Rena Feinman, PhD, Robert Korngold, PhD, Michele L. Donato, MD, Scott D. Rowley, MD, Themba Nyirenda, PhD, Andrew L. Pecora, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5618.
https://doi.org/10.1182/blood-2019-132025
Published: 2019
Journal Articles

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Katsumi Nishiya, MD, PhD, Ichiro Tanaka, MD, PhD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Koji Yada, MD, Tomoko Matsumoto, Midori Shima, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3320.
https://doi.org/10.1182/blood.V118.21.3320.3320
Published: 2011
Journal Articles

Arterial Wall Thickness: Marker of Atherosclerosis or Risk Factor for Thrombosis

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi
Journal: Blood
Blood (2008) 112 (11): 5470.
https://doi.org/10.1182/blood.V112.11.5470.5470
Published: 2008
Journal Articles

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

Marcelo A. Navarrete, MD, Kristina Heining-Mikesch, MD, Cristina Bertinetti-Lapatki, PhD, Marcus Duehren-von Minden, Andrea Hafkemeyer, MD, Hendrik Veelken, MD
Journal: Blood
Blood (2008) 112 (11): 235.
https://doi.org/10.1182/blood.V112.11.235.235
Published: 2008